Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 October, 2018 17:21 IST
Suven Life Sciences secures 2 overseas product patents
Source: IRIS | 06 Dec, 2017, 10.35AM
Comments  |  Post Comment

Suven Life Sciences announces today that the grant of one product patent from Eurasia and one product patent from Norway corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034 and 2026 respectively.

The granted claims of the patents include the class of selective 5-HT6 compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia.

''We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,'' said Venkat Jasti, CEO of Suven. 

Shares of the company gained Rs 8, or 4.2%, to trade at Rs 198.55. The total volume of shares traded was 15,809 at the BSE (10.24 a.m., Wednesday).



Suven Life Sciences Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Zydus receives USFDA's final approval for Clobazam tablets - 23-Oct-2018 15:01
Ahluwalia Contracts wins new orders of worth Rs 5.38 bn - 23-Oct-2018 11:58
PNB Housing Finance raises Rs 17.75 bn through commercial papers - 23-Oct-2018 10:22
White Organic Agro bags additional orders from Innovative Cuisine - 23-Oct-2018 10:16
Himachal Futuristic Communications secures order worth Rs 3.66 bn - 23-Oct-2018 10:07
Lupin gets nod for generic Triamcinolone Acetonide ointment - 23-Oct-2018 10:00
ITD Cementation India bags orders worth Rs 10.66 bn - 23-Oct-2018 09:35
Biocon, Mylan announce positive CHMP Opinion for Ogivri - 22-Oct-2018 10:28
Lupin announces positive CHMP opinion for NaMuscla - 22-Oct-2018 09:51
Tejas Networks bags Rs 1.11 bn order from Sterlite Technologies - 22-Oct-2018 09:45
Alembic Pharma' JV completes USFDA inspection of Karakhadi unit - 22-Oct-2018 09:41
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer